Expression of Mfn2, the Charcot-Marie-Tooth neuropathy type 2A gene, in human skeletal muscle: effects of type 2 diabetes, obesity, weight loss, and the regulatory role of tumor necrosis factor alpha and interleukin-6

Bach, Daniel; Naon, Deborah; Pich, Sara; Soriano, Francesc X.; Vega, Nathalie; Rieusset, Jennifer; Laville, Martine; Guillet, Christelle; Boirie, Yves; Wallberg-Henriksson, Harriet; Manco, Melania; Calvani, Menotti; Castagneto, Marco; Palacín, Manuel; Mingrone, Geltrude; Zierath, Juleen R.; Vidal, Hubert; Zorzano, Antonio; Palacín, Manuel
September 2005
Diabetes;Sep2005, Vol. 54 Issue 9, p2685
Academic Journal
journal article
The primary gene mutated in Charcot-Marie-Tooth type 2A is mitofusin-2 (Mfn2). Mfn2 encodes a mitochondrial protein that participates in the maintenance of the mitochondrial network and that regulates mitochondrial metabolism and intracellular signaling. The potential for regulation of human Mfn2 gene expression in vivo is largely unknown. Based on the presence of mitochondrial dysfunction in insulin-resistant conditions, we have examined whether Mfn2 expression is dysregulated in skeletal muscle from obese or nonobese type 2 diabetic subjects, whether muscle Mfn2 expression is regulated by body weight loss, and the potential regulatory role of tumor necrosis factor (TNF)α or interleukin-6. We show that mRNA concentration of Mfn2 is decreased in skeletal muscle from both male and female obese subjects. Muscle Mfn2 expression was also reduced in lean or in obese type 2 diabetic patients. There was a strong negative correlation between the Mfn2 expression and the BMI in nondiabetic and type 2 diabetic subjects. A positive correlation between the Mfn2 expression and the insulin sensitivity was also detected in nondiabetic and type 2 diabetic subjects. To determine the effect of weight loss on Mfn2 mRNA expression, six morbidly obese subjects were subjected to weight loss by bilio-pancreatic diversion. Mean expression of muscle Mfn2 mRNA increased threefold after reduction in body weight, and a positive correlation between muscle Mfn2 expression and insulin sensitivity was again detected. In vitro experiments revealed an inhibitory effect of TNFα or interleukin-6 on Mfn2 expression in cultured cells. We conclude that body weight loss upregulates the expression of Mfn2 mRNA in skeletal muscle of obese humans, type 2 diabetes downregulates the expression of Mfn2 mRNA in skeletal muscle, Mfn2 expression in skeletal muscle is directly proportional to insulin sensitivity and is inversely proportional to the BMI, TNFα and interleukin-6 downregulate Mfn2 expression and may participate in the dysregulation of Mfn2 expression in obesity or type 2 diabetes, and the in vivo modulation of Mfn2 mRNA levels is an additional level of regulation for the control of muscle metabolism and could provide a molecular mechanism for alterations in mitochondrial function in obesity or type 2 diabetes. Diabetes 54: 2685-2693, 2005


Related Articles

  • Plasma adipokine and inflammatory marker concentrations are altered in obese, as opposed to non-obese, type 2 diabetes patients. Hansen, Dominique; Dendale, Paul; Beelen, Milou; Jonkers, Richard A. M.; Mullens, Annelies; Corluy, Luk; Meeusen, Romain; van Loon, Luc J. C. // European Journal of Applied Physiology;Jun2010, Vol. 109 Issue 3, p397 

    Elevated plasma free fatty acid (FFA), inflammatory marker, and altered adipokine concentrations have been observed in obese type 2 diabetes patients. It remains unclear whether these altered plasma concentrations are related to the diabetic state or presence of obesity. In this cross-sectional...

  • Pregnancy-Associated Plasma Protein-A Levels Are Related to Glycemic Control but Not to Lipid Profile or Hemostatic Parameters in Type 2 Diabetes. Pellitero, Silvia; Reverter, Jordi L.; Pizarro, Eduarda; Pastor, Maria Cruz; Granada, Maria Luisa; Tàssies, Dolors; Reverter, Juan-Carlos; Salinas, Isabel; Sanmartí, Anna // Diabetes Care;Dec2007, Vol. 30 Issue 12, p3083 

    The article highlights a study on the relationship between pregnancy-associated plasma protein-A (PAPP-A), glycemic control and other metabolic and hemostatic parameters, inflammatory cytokines and ankle-brachial pressure index (ABI) in type 2 diabetic patients. It was shown that PAPP-A levels...

  • Loss of Nix in Pdx1-deficient mice prevents apoptotic and necrotic β cell death and diabetes. Fujimoto, Kei; Ford, Eric L.; Hung Tran; Wice, Burton M.; Crosby, Seth D.; Dorn II, Gerald W.; Polonsky, Kenneth S.; Tran, Hung; Dorn, Gerald W 2nd // Journal of Clinical Investigation;Nov2010, Vol. 120 Issue 11, p4031 

    Mutations in pancreatic duodenal homeobox (PDX1) are linked to human type 2 diabetes and maturity-onset diabetes of the young type 4. Consistent with this, Pdx1-haploinsufficient mice develop diabetes. Both apoptosis and necrosis of β cells are mechanistically implicated in diabetes in these...

  • Adipokines and Hepatic Insulin Resistance. Yu Li; Lin Ding; Hassan, Waseem; Abdelkader, Daoud; Jing Shang // Journal of Diabetes Research;2013, p1 

    Obesity is a major risk factor for insulin resistance and type 2 diabetes. Adipose tissue is now considered to be an active endocrine organ that secretes various adipokines such as adiponectin, leptin, resist in, tumour necrosis factor-α, and interleukin-6. Recent studies have shown that...

  • Glucose-Sensing by POMC Neurons Is Impaired in Obesity and Is Regulated by UCP2. Parton, Laura E.; Ye, Chianping; Coppari, Roberto; Enriori, Pablo J.; Choi, Brian; Chen-Yu Zhang; Chun Xu; Vianna, Claudia R.; Lee, Charlotte E.; Elmquist, Joel K.; Cowley, Michaela; Lowell, Bradford B. // Diabetes;Jun2007 Supplement 1, Vol. 56, pA7 

    A subset of neurons, known as "glucose-excited" neurons, depolarize and increase their firing rate in response to physiological increases in extracellular glucose. As for insulin secretion by pancreatic β-cells, glucose excitation of neurons is driven by ATP-mediated closure of K[sub ATP]...

  • Deletion of SOCS7 leads to enhanced insulin action and enlarged islets of Langerhans. Banks, Alexander S.; Jianze Li; McKeag, Lisa; Hribal, Marta L.; Kashiwada, Masaki; Accili, Domenico; Rothman, Paul B.; Li, Jianze // Journal of Clinical Investigation;Sep2005, Vol. 115 Issue 9, p2462 

    NIDDM is characterized by progressive insulin resistance and the failure of insulin-producing pancreatic beta cells to compensate for this resistance. Hyperinsulinemia, inflammation, and prolonged activation of the insulin receptor (INSR) have been shown to induce insulin resistance by...

  • Association Between Raised Inflammatory Markers and Cognitive Decline in Elderly People With Type 2 Diabetes. Marioni, Riccardo E.; Strachan, Mark W. J.; Reynolds, Rebecca M.; Lowe, Gordon D. O.; Mitchell, Rory J.; Fowkes, F. Gerry R.; Frier, Brian M.; Lee, Amanda J.; Butcher, Isabella; Rumley, Ann; Murray, Gordon D.; Deary, Ian J.; Price, Jackie F. // Diabetes;Mar2010, Vol. 59 Issue 3, p710 

    OBJECTIVE--To determine whether circulating levels of the inflammatory markers C-reactive protein (CRP), interleukin (IL)-6, and tumor necrosis factor (TNF)-α are associated with cognitive ability and estimated lifetime cognitive decline in an elderly population with type 2 diabetes. RESEARCH...

  • Postprandial Increase in IL 6 and TNFα Is Reduced by a Basal + Prandial Insulin Regimen Compared With a Basal Insulin Regimen in Type 2 Diabetes (T2D) Patients. Tan, Meng H.; Brown, W. Virgil; Goldberg, Ronald B.; Ceriello, Antonio; Beisswenger, Paul J.; Le, Ngoc-Anh; Sarwat, Samiha; Jones, Cate A.; Milicevic, Zvonko; Robbins, David C. // Diabetes;Jun2007 Supplement 1, Vol. 56, pA174 

    We compared the effects of basal+prandial insulin lispro mid mix (MM) (50% NPL, 50% lispro) ac tid with basal insulin glargine (G) hs, both plus metformin (Met), on postprandial (pp) blood glucose (BG), insulin, and inflammatory markers (IL 6 and TNFα) in T2D patients before and after 24 wks...

  • Association of IL- 6, TNF- α and IL- 10 gene polymorphisms with type 2 diabetes mellitus. Saxena, Madhukar; Srivastava, Neena; Banerjee, Monisha // Molecular Biology Reports;Nov2013, Vol. 40 Issue 11, p6271 

    Type 2 diabetes mellitus (T2DM) is a metabolic pro-inflammatory disorder characterized by chronic hyperglycemia and increased levels of circulating cytokines suggesting a causal role of inflammation in its etiology. Polymorphism of cytokine genes including interleukin-6 ( IL- 6), tumour necrosis...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics